AzTrials
AzTrials

Autism Spectrum DisorderNCT05520632

Autism Spectrum Disorder: BAEPs Findings and Behavioral Responses to Sounds

An observational study of Autism Spectrum Disorder, run by Instituto de Ciências Biomédicas Abel Salazar at 1 site in Portugal.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

There are many studies in the literature that study the sensory profile of children with autism spectrum disorder (ASD), which can essentially have three types of behavior: (1) Registration, (2) Seeking, (3) Sensitivity, and (4) Avoiding. Read more about this study

Who is it for?
Ages 3 to 6 yearsHealthy volunteers can take part
Conditions the study is for
Autism Spectrum Disorder
What is being tested?
Brainstem Auditory Evoked Potentials
How many people
120 participants
Where
1 sitePortugal
Study dates
1 May 2022to 1 Dec 2026
How long will I take part?
3 Years
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 6 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: All cases as children sent/followed up in the Development Consultation - Pediatrics, Pedopsychiatry or Pediatric Neurology diagnosed with ASD aged between 2 and 6 years (possible cases) and all children aged between 2 and 6 years who had scheduled PEATC in the ENT service in routine care (possible controls)

Who may be able to join

  • Case group: children diagnosed with ASD according to the DSM-V criteria (Diagnostic and Statistical Manual of Mental Disorders 5th edition) and performed by a Pediatrician, Pedopsychiatry or Pediatric Neurologist; age between 3 and 6 years at the time of the audiological assessment; children with indication for BAEP; children who reveal thresholds within the normal range in the BAEP.
  • Control group: children with typical development for their age; children with indication for BAEP due to the presence of risk factors for deafness (included in the universal neonatal auditory screening program) or due to delay in language development alone requiring clarification; age between 3 and 6 years at the time of audiological examinations; children who reveal thresholds within the normal range in the BAEP.

Who cannot join

  • Case group: late diagnosis of ASD (> 6 years); associated pathology, such as: neurological (epilepsy, neurodegenerative disease, severe hypoxic-ischemic encephalopathy), congenital infections (TORCH group infections) with hearing impairment, chromosomal abnormalities (Down syndrome, fragile X syndrome), neurocutaneous syndromes, endocrine disorders and metabolic disorders (phenylketonuria), cleft palate or facial malformations; active ear pathology at the time of audiological evaluation (otitis media, external auditory canal infection or malformation); increase in auditory thresholds in BAEP.
  • Control group: associated pathology, such as: neurological (epilepsy, neurodegenerative disease, severe hypoxic-ischemic encephalopathy), congenital infections (TORCH group infections) with hearing loss, chromosomal abnormalities (Down syndrome, fragile X syndrome), neurocutaneous syndromes , endocrine and metabolic disorders (phenylketonuria), cleft palate or facial malformations; active ear pathology at the time of audiological evaluation (otitis media, external auditory canal infection or malformation); increase in auditory thresholds in BAEP.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Portugal1 site, 1 recruiting
  • Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto (Abel Salazar Biomedical Sciences Institute - University of Porto)

    Porto, 4050-313

    Joana Raquel Correia Carvalho da Costa, 918109458, joana_cccosta@hotmail.com

    Recruiting

Other trials in Portugal

About this study

Official title: Autism Spectrum Disorder: Brainstem Auditory Evoked Potential Findings and Behavioral Responses to Sounds

There are many studies in the literature that study the sensory profile of children with autism spectrum disorder (ASD), which can essentially have three types of behavior: (1) Registration, (2) Seeking, (3) Sensitivity, and (4) Avoiding. However, there are few studies dedicated to the study of the sensory profile of children with autism. A child's sensory profile is closely related to the way they deal with the world and their social interaction. The existence of tools that allow the study of the behavioral response to the sounds of children with autism spectrum disorder, will allow the application of targeted therapies in the future. Therapies targeted and adjusted to each profile observed in these children will allow to attenuate these maladjusted behavioral responses, or even overcome these deficits, if there is an early and precise intervention.

Read the detailed description

The objectives of this work are:

PRIMARY OBJECTIVES:

  • To characterize the BAEP findings in children with ASD (case group) and compare these findings with those obtained in children matched by sex and age without suspected ASD (control group), with a special focus on the study of the following parameters:
  1. Wave I amplitude and wave V/wave I amplitude ratio (V/I ratio)
  2. Extension of the absolute latency of wave V With the aim of:
  • Establish and describe a possible pattern in the BAEP that characterizes children with ASD
  • To characterize the subgroup of children with ASD who present alterations in the BAEP: understand if changes in BAEPs appear in children with more severe autism, if it depends on gender, if it depends on the auditory profile.
  • Characterize the Behavioral Response to Sounds of children with ASD
  1. Application and validation for Portuguese of the Auditory Behavior Questionnaire (ABQ)
  2. Application of Child Sensory Profile 2 (CSP2) With the aim of. > To characterize the audiological profile of children with ASD
  • To establish, among children with ASD, a relationship between the specific findings in the BAEP and different behavioral responses to sound.

SECONDARY OBJECTIVES:

  • Collect and analyze demographic data;
  • Collect and analyze the personal (pre, peri and postnatal) and family history of each participant;
  • Assess the degree of global development and in particular the hearing/language parameter through data collected from the Griffiths Mental Development Scale;
  • Characterize ASD in terms of severity, clinician/specialty that made the diagnosis;
  • Evaluate other additional parameters of the BAEP: describe the uni or bilaterality of the findings; analyze the latency of waves III and increase in interpeak intervals for waves I-III and I-V.

MATERIAL AND METHODS

  1. Study design: Analytical observational case-control study
  2. Participants This study will include children between 3 and 6 years of age, observed consecutively at the Otorhinolaryngology Service of the Porto University Hospital Center and the Pediatrics Service of the Northern Mother and Child Center (belonging to the Porto University Hospital Center), with a diagnosis of ASD. with indication for performing BAEP.
  3. Study groups The sample will be divided into two groups:
  • Children with ASD (ASD Group): cases
  • Children without diagnosis or suspicion of ASD (Group without ASD): control
  1. Recruitment All children sent/followed at the Development Consultation - Pediatrics, Pedopsychiatry or Pediatric Neurology diagnosed with ASD aged between 2 and 6 years (potential cases) and all children aged between 2 and 6 years who have BAEP appointments in the Otorhinolaryngology department (potential controls) will be sent to the principal investigator. Thus, a consecutive and progressive recruitment of participants will be carried out. Parents or guardians of children who meet the inclusion criteria will be asked about their availability and interest in participating in the study, explaining the purpose of the study. An Information Leaflet for Participants has been created. If they wanted to participate in the study after being duly informed, an Informed Consent Term is delivered and signed. An individual data collection sheet was also created for data collection by the researcher. Data obtained from the electronic clinical file and provided by the parents. The aforementioned and scheduled BAEP questionnaires will be applied. After performing the BAEP, a new consultation is scheduled with the parents/legal guardians, where the result of the new assessment in terms of sensory and auditory profile, as well as the results of the BAEP will be made known. All data collected will go into a database created for this purpose.
  2. Time line

This study will be developed in 4 main stages:

  1. st PHASE: Preparation phase
  • Elaboration of the Study Protocol
  • Submission of the Project to the Ethics Committee
  • Preparation of information leaflets, consents, sheet/database for data collection
  • Creation of referral routes between the Principal Investigator and the doctors dedicated to the Development Consultation - Pediatrics, who deal with children diagnosed with ASD and with the audiologists responsible for carrying out the BAEP, in order to constitute the study sample.
  • Translation and validation of the Auditory Behavior Questionnaire
  1. nd PHASE: Selection of possible study patients and data collection
  • Consecutive and progressive recruitment of participants. At this stage, the parents of children who meet the inclusion and exclusion criteria will be summoned, and asked about their availability to participate in the study;
  • The respondents that make up the study will be applied;
  • Will be requested by the BAEP researcher
  1. rd PHASE: Creation of a database
  • Collection of information from BAEP;
  • All information collected and recorded on the "Individual Data Collection Sheet" in phase 2 of the study will be transferred to a database.
  1. th PHASE: Data analysis and interpretation of results (2 months) The researchers and statistical analysts, using the appropriate statistical tests, will proceed to the analysis of the collected data. Subsequently, an interpretation will be made of the results of the study and a comparison with existing data in the literature in order to draw up the conclusions of the study and its dissemination in Research Article format and its presentation in free communication format at scientific events. .
  2. Ethical considerations

During the realization of this study, we will act according to the medical ethics requirements defined in the World Medical Association Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. Thus, this project was submitted to the Ethics Committee for Health of the Porto University Hospital Center, obtaining a favorable opinion in May/2022 (2021-124 (101-DEFI/104-CE)).

Being tested
Brainstem Auditory Evoked Potentials
Medical subject headings
Autism Spectrum Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Brainstem Auditory Evoked PotentialsDiagnostic test

    Performing Brainstem Auditory Evoked Potentials under sedation

Study groups in NCT05520632
Study groupRoleWhat they receive
Children without autism spectrum disorderChildren without autism spectrum disorder undergoing BAEP
Receives: Diagnostic Test: Brainstem Auditory Evoked Potentials
Children with autism spectrum disorderChildren with autism spectrum disorder undergoing BAEP
Receives: Diagnostic Test: Brainstem Auditory Evoked Potentials

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Findings in Brainstem Auditory Evoked Potentials (BAEP)

    Brainstem Auditory Evoked Potentials will be performed under propofol sedation. Absolute latencies (ALs) of waves I, III, and V and interpeak latencies (IPLs) I-III, III-V, and I-V were measured, as well as the amplitudes of waves I and V. These values will be compared between the group of cases (children with ASD) and controls (children without ASD). It will be evaluated whether any of these values will be persistently outside the values considered normal in children with ASD.

    Measured: 3 years

Secondary outcomes (2)
  1. Study of the sensory profile of children with autism spectrum disorder applying the "Child Sensory Profile 2" questionnaire

    Application of the questionnaire "Child Sensory Profile 2" (CSP2) and determine which category stands out: (1) Registration, (2) Seeking, (3) Sensitivity, and (4) Avoiding.

    A 5-point Likert scale (1 = almost never, 2 = occasionally, 3 = Half the time, 4 = Frequently, 5 = Almost always) will be applied to each question. A standard factor score close to zero suggests a child exhibits behaviors in that factor domain that are consistent with the majority of children. A more positive standard factor score suggests the child displays more of the observed behaviors associated with that domain than other children in this sample with ASD.

    A raw score total will be obtained for each category. Scores one standard deviation or more from the mean as expressed as "More than Others" or "Less than Others". Scotes two standard deviations or more from the mean area expressed as "Much more than the Others" or "Much less than Others", respectively.

    Measured: 3 years

  2. Study of the auditory profile of children with autism spectrum disorder applying the"Auditory Behavior Questionnaire" questionnaire

    Application of the questionnaire "Auditory Behavior Questionnaire" (ABR) and determine which category stands out in terms of auditory profile: (1) Registration, (2) Seeking, (3) Sensitivity, and (4) Avoiding.

    A 5-point Likert scale (1 = Never, 2 = Rarely, 3 = Sometimes, 4 = Often, 5 = Very Often.

    A a score close to zero suggests a child exhibits behaviors in that factor domain that is consistent with the majority of children with ASD. If a child has a negative standard score then the behaviors are less prevalent associated with that factor domain. A more positive standard score suggests more difficulty in the specified factor and a higher prevalence of the observed behaviors for that child.

    Measured: 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Aug 2022
  2. Study start1 May 2022
  3. Primary completion1 May 2023 (estimated)
  4. Study completion1 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
120 participants (estimated)
Target duration
3 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT05520632
Sponsor's protocol ID
2021.124(101.DEFI/104-CE)
Status last verified
Aug 2022
First submitted
22 Aug 2022
Last updated
30 Aug 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Autism Spectrum Disorder, run by Instituto de Ciências Biomédicas Abel Salazar at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Joana Costa, MD (00351918109458, joana_cccosta@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Findings in Brainstem Auditory Evoked Potentials (BAEP) (time frame: 3 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Aug 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in